Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Abstract
Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.
Topics & Concepts
MedicineBiliary tract cancerImmunotherapyCancerBiliary tractBiomarkerIntensive care medicineInternal medicineGemcitabineBiochemistryChemistryCholangiocarcinoma and Gallbladder Cancer StudiesPeptidase Inhibition and AnalysisGallbladder and Bile Duct Disorders